131 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
Pharma’s team has delivered innovative treatments to rare disease patients with high unmet medical needs. By joining forces and expertise we will be able … Global Rare Diseases
Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Apr 23
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
9:00am
2023.
About Amryt
Amryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those … -stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments to help improve the lives of patients
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, developing and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong … and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing
6-K
EX-99.1
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
.
About AmrytAmryt is a global commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments
6-K
EX-99.2
slxqiob6
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.3
r2mmsehvjjtj fkm7o4i
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.5
jfy5osk8vvm26d0zadg
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.4
oljq nknmqv
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
xxcd0 2ht
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.2
w9c7x
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.4
ip9vj6
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
6yimjx 6brkm
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.5
e4w sp6c7z
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.3
9rnblux5v
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.1
3cibu1er5h
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.4
z9r7h 4g7qy1ge
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.2
v3mdshgt39 5vdg1fz
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
6-K
EX-99.1
az9ouszhk5c b4dmvsaw
24 Jun 22
Filsuvez® recently approved by the European Commission for the treatment of EB
7:18am
6-K
EX-99.1
akhphl
23 Jun 22
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB
7:26am